Group A streptococcal infection (SGA) is an acute infectious disease caused by the β-hemolytic streptococcus group A (Streptococcus pyogenes). These organisms can cause a wide range of illnesses, from mild forms such as pharyngitis and tonsillitis to severe forms such as sepsis and necrotizing fasciitis. The infection often presents with pronounced symptoms, including sore throat, fever, purulent plugs in the tonsils, and general malaise. The infection can also lead to complications such as rheumatic fever and poststreptococcal glomerulonephritis. Spread of group A streptococci in the population occurs primarily through the airborne route, as well as through contact with objects that may have become contaminated.
History of the disease and interesting historical facts
The history of group A streptococcal infections goes back centuries. In the 19th century, streptococci A were identified as the causative agents of various diseases, including scarlet fever and strep throat. In the 1920s, the philosophy of treating streptococcal infections changed significantly with the discovery of antibiotics. However, to this day, group A streptococci remain an important cause of illness. One interesting historical fact is that the 1930s saw a boom in scientific research related to these bacteria, which ultimately led to a deeper understanding of the pathogenesis and the formation of new methods for diagnosing and treating streptococcal infections.
Epidemiology
The epidemiology of group A streptococcal infections shows considerable variation worldwide. According to the World Health Organization, one in five upper respiratory tract infections in children is due to group A streptococcus. In developing countries, the incidence of streptococcal infections is much higher, especially in densely populated settings with poor sanitation. An estimated 18.1 million cases of rheumatic fever occur worldwide each year, most of which are due to SGA infections. In addition, outbreaks associated with low vaccination and prophylaxis rates have occurred in some regions.
Genetic predisposition to this disease
Genetic predisposition to group A streptococcal infections may be due to immune response characteristics. It has been established that some genes associated with the HLA (Human Leukocyte Antigen) system play an important role in susceptibility to these infections. In particular, the HLA-DR and HLA-DQ genes may predispose individuals to streptococcal infections. Studies show that mutations in genes responsible for the production of interleukins and other cytokines may also influence the development and course of SGA infections. Therefore, genetic factors may largely determine how severely a particular individual develops a streptococcal infection and how quickly he or she will recover after treatment.
Risk factors for the development of this disease
There are a number of risk factors that contribute to the development of group A streptococcal infections, including:
- Disorders of the immune system (immunodeficiencies, allergies).
- Industrial and environmental factors (pollution, contact with chemicals).
- Age (especially in younger children).
- The presence of concomitant diseases (diabetes, lung diseases).
- Population density and living conditions (overcrowded premises, poor sanitation).
- Incorrect treatment of infections caused by other pathogens leading to immunosuppression.
These factors interact with each other to increase the risk of disease, especially in high-risk groups such as children and the elderly.
Diagnosis of this disease
Diagnosis of group A streptococcal infections is based on clinical manifestations and laboratory tests. The main symptoms that may indicate a streptococcal infection include:
- Sore throat, especially acute onset.
- Increased body temperature.
- Redness and swelling of the tonsils, possible presence of purulent plugs.
- Pain when swallowing.
- General malaise, headache.
Laboratory tests that help make a diagnosis include:
- Rapid streptococcal antigen tests that provide results in 10-15 minutes.
- Clinical blood test to determine the level of leukocytes.
- Throat culture for SGA, which allows confirmation of the diagnosis and determination of antibiotic sensitivity.
Radiological examinations are not mandatory, but in some cases, for example, if complications are suspected, X-rays or ultrasound may be used. Differential diagnosis should be made with diseases such as mononucleosis, any viral infections, allergic reactions and other bacterial infections.
Treatment
Treatment of group A streptococcal infections includes both general and specific approaches. General treatment includes bed rest and plenty of fluids to prevent dehydration. Pharmacological treatment is based on the use of antibiotics. The most commonly used are:
- Penicillins (eg, benzathine penicillin).
- Macrolides (eg, azithromycin) for patients allergic to penicillin.
Surgery may be necessary if abscesses form or if serious complications such as necrotizing fasciitis occur. Other treatments may include symptomatic therapy, such as antipyretics and throat relievers. It is important to remember that taking the full course of antibiotics is important to prevent complications such as rheumatic fever.
List of medications used to treat this disease
List of the most common medications used to treat group A streptococcal infections:
- Benzathine penicillin.
- Amoxicillin.
- Azithromycin.
- Cephalexin.
- Clarithromycin.
These antibiotics help eliminate the infection and prevent it from spreading.
Disease monitoring
Monitoring of group A streptococcal infections requires periodic assessment of the patient's clinical status, particularly during the first week of treatment. Monitoring steps include:
- Assessment of symptoms (reduction of pain, temperature).
- Laboratory tests (repeat tests for strep).
- Dynamics of the general condition (absence of new symptoms, improvement of well-being).
The prognosis with timely and adequate treatment is generally good. However, complications such as rheumatic fever may occur several weeks after the initial infection. It is also important to inform patients of the need for a full course of antibiotic therapy to prevent relapses and complications.
Age-related features of the disease
Infections caused by group A streptococci may present differently in different age groups. In young children, the clinical picture most often includes acute pharyngitis and tonsillitis, and the infection may be accompanied by high fever and severe intoxication. In adolescence, streptococcal infections can lead to serious complications, such as rheumatic fever. In older people, the infection often occurs with more subtle symptoms and can become protracted, which is associated with a weakened immune system.
Questions and Answers
- What are the main symptoms of group A streptococcal infection? The main symptoms include sore throat, fever, redness and swelling of the tonsils, the presence of purulent plugs and general malaise.
- How to diagnose group A streptococcal infection? Diagnosis includes clinical examination and laboratory methods such as rapid antigen testing and bacterial culture.
- What is the treatment for group A streptococcal infections? Treatment includes antibiotics, most often penicillins and macrolides, as well as symptomatic therapy.
- What are the potential complications of streptococcal infections? Possible complications include rheumatic fever and poststreptococcal glomerulonephritis.
- Who is at risk for developing streptococcal infections? Those at risk include young children, the elderly, immunocompromised patients and those living in crowded conditions.
